[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583013":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":59,"collaborators":24,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":24,"enrollmentInfo":71,"targetDuration":24,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":45,"whyStopped":24,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Zurich","OTHER",[8,14],{"label":9,"type":6,"description":10,"interventionNames":11},"Closed Mask followed by No Mask","The first half of the treatment is delivered with a face mask, the second half is delivered without mask using surface guidance only",[12,13],"Device: Surface guided radiation therapy","Device: Closed face mask",{"label":15,"type":6,"description":16,"interventionNames":17},"No Mask followed by Closed Mask","The first half of the treatment is delivered without mask using surface guidance only, the second half is delivered with a face mask",[12,13],[19,25],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Surface guided radiation therapy","Radiation therapy will be delivered using no immobilization mask, but a surface guided system with infrared light",[9,15],null,{"type":20,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Closed face mask","Radiotherapy with closed face mask for immobilization",[9,15],[30],{"name":31,"affiliation":5,"role":32},"Panagiotis Balermpas, Prof. Dr.","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":24,"email":38},"Katerina Nilo","CONTACT","+41 44 255 35 66","ina.nilo@usz.ch",{"name":40,"role":36,"phone":24,"phoneExt":24,"email":41},"Crystal Sulaiman","Crystal.Sulaiman@usz.ch",[43],{"facility":44,"status":45,"city":46,"state":24,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University Hospital Zurich","RECRUITING","Zurich","8091","Switzerland","CH",{"type":51,"coordinates":52},"Point",[53,54],8.55,47.36667,{"lat":54,"lon":53},[57],{"name":31,"role":36,"phone":24,"phoneExt":24,"email":58},"panagiotis.balermpas@usz.ch",{"type":60,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100583013","comparing-closed-face-masks-vs-surface-guided-radiation-therapy-for-head-and-neck-radiotherapy-100583013",false,"NCT06870799","Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy","Randomized Controlled Trial Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy","NoMask","Inclusion Criteria:\n\n* Written informed consent according to Swiss law and ICH\u002FGCP regulations before any trial specific procedures;\n* Indication for head and neck radiotherapy irrespective of tumor type;\n* Age: ≥ 18 years old;\n* Karnofsky performance status ≥70;\n* Patients who are willing and able to comply with scheduled visits, treatment, and other trial procedures.\n\nExclusion Criteria:\n\n* Prior head and neck irradiation;\n* Women who are pregnant or breast feeding;\n* Intention to become pregnant during the course of the trial;\n* Lack of safe contraception, defined as: Female participants of childbearing potential, not using and not willing to continue using a medically reliable method of contraception for the entire study duration, such as oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices, or who are not using any other method considered sufficiently reliable by the investigator in individual cases;\n* Known or suspected non-compliance, drug or alcohol abuse;\n* Inability to follow the procedures of the trial, e.g. due to language problems of the participant;\n* Enrolment of the investigator, his\u002Fher family members, employees and other dependent persons.\n* One of the following Tumor Types: Nasopharynx, Sinunasal, patients with CTV within 5 mm of eyes or spinal cord.","ALL","18 Years",{"count":72,"type":73},25,"ESTIMATED","INTERVENTIONAL",[76],"NA","At present, open-face masks are used only in patients with claustrophobic anxiety, while all other patients are still immobilized with closed masks, thereby overlooking the need for improvement in patient comfort. Closed face masks in patients undergoing head and neck irradiation have never been compared to no masks in the setting of a randomized clinical trial, but only in feasibility trials. A randomized clinical trial may establish the role of no masks in terms of patient comfort, preference and setup accuracy in all patients.",[79],"Head and Neck Cancers",[81,82,83,84],"head and neck cancer","face mask","surface guidance","radiation therapy","2025-05-16",{"date":87,"type":88},"2025-05-18","ACTUAL",{"date":90,"type":88},"2025-05-12",{"date":92,"type":73},"2027-05",{"name":5,"class":6},1]